GalNAc-T9 represents an intriguing enzyme in the family of GalNAc-transferases, key players in the intricate process of O-linked glycosylation. This specific enzyme facilitates the transfer of N-acetylgalactosamine onto serine and threonine residues within proteins, a fundamental step in the synthesis of the glycoprotein mucin. The expression of GalNAc-T9 within cellular systems is a finely tuned process, influenced by a variety of intracellular and extracellular signals. Understanding the regulation of GalNAc-T9 is pivotal for comprehending the glycosylation patterns that are critical for numerous cellular functions, including cell signaling, protein stability, and the establishment of cell-cell interactions. Research into the molecular pathways that govern the expression of GalNAc-T9 enzyme can shed light on the complex regulatory networks that dictate the glycosylation landscape within cells, offering insights into the basic principles of cellular operation and the maintenance of cellular health.
Various biochemical compounds have been identified that can potentially induce the expression of GalNAc-T9. Compounds such as retinoic acid and beta-estradiol can have a significant role in the transcriptional activation of genes, including those involved in glycosylation processes. These molecules bind to specific receptors that interact with DNA at promoter regions of target genes to stimulate transcription. Other molecules, like butyrate and its derivative sodium butyrate, act epigenetically through the inhibition of histone deacetylases, which leads to a more relaxed chromatin state and can result in increased transcriptional activity. Additionally, agents such as 5-Azacytidine and epigallocatechin gallate may induce expression by altering the epigenetic marks on the DNA, thereby affecting gene expression profiles. The induction of stress responses within the cell, for instance through the administration of tunicamycin or thapsigargin, can also lead to the upregulation of proteins involved in glycosylation, as the cell endeavors to manage the stress by modifying its protein folding machinery. Collectively, these activators highlight the diverse molecular mechanisms through which the expression of GalNAc-T9 can be regulated, further emphasizing the complexity of cellular regulation and the intricacies of protein glycosylation.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid can upregulate gene expression by binding to retinoic acid receptors, potentially stimulating the transcription of GalNAc-T9 by altering transcriptional control at gene promoter sites. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Epigallocatechin gallate has been shown to possess epigenetic modulatory properties that may stimulate the transcription machinery related to the expression of GalNAc-T9 through alterations in DNA methylation and histone modification patterns. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
By inhibiting DNA methyltransferases, 5-Azacytidine may reactivate epigenetically silenced genes, thereby potentially increasing the expression levels of GalNAc-T9 through demethylation of the gene's promoter region. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin may elevate intracellular cAMP, which in turn could activate protein kinase A (PKA) and subsequent transcription factors that stimulate GalNAc-T9 gene transcription. | ||||||
1α,25-Dihydroxyvitamin D3 | 32222-06-3 | sc-202877B sc-202877A sc-202877C sc-202877D sc-202877 | 50 µg 1 mg 5 mg 10 mg 100 µg | $220.00 $645.00 $1000.00 $1500.00 $440.00 | 32 | |
The hormonally active form of vitamin D3, Calcitriol, can bind to its receptor and stimulate the transcription of genes involved in calcium metabolism, potentially including the upregulation of GalNAc-T9. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A, as an HDAC inhibitor, may promote histone acetylation, thereby stimulating an increase in the transcriptional activity of genes such as GalNAc-T9 by allowing transcription factor access. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
Tunicamycin may induce the unfolded protein response (UPR) by inhibiting N-linked glycosylation, which can lead to the upregulation of several genes involved in protein folding, including possibly GalNAc-T9. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin could induce the expression of GalNAc-T9 by disrupting calcium homeostasis within the endoplasmic reticulum, triggering the UPR and leading to an adaptive response that may include the upregulation of GalNAc-T9. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Similar to butyrate, sodium butyrate might stimulate the expression of GalNAc-T9 through inhibition of HDACs, resulting in an open chromatin conformation and subsequent transcriptional activation of the gene. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
Mithramycin A can bind to DNA and selectively inhibit Sp1 transcription factor binding to GC-rich promoter regions, potentially stimulating the transcription of specific genes, including those encoding glycosyltransferases like GalNAc-T9. | ||||||